(Q28206236)

English
No label defined

scientific article (publication date: March 2002)

Statements

Nucleophosmin-anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino,17-demethoxygeldanamycin (English)
0 references
Paolo Bonvini
0 references
Tamara Gastaldi
0 references
Brunangelo Falini
0 references
Angelo Rosolen
0 references
1 March 2002
0 references
62
0 references
1559-66
0 references
5
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit